Posted today in FDA Alerts

ED-530XT Duodenoscopes by Fujifilm: Safety Communication - Recall Issued, Updated Design and Labeling

[Posted 07/21/2017] ISSUE: On July 21, 2017, Fujifilm issued an Urgent Medical Device Correction and Removal notification informing customers of its voluntary recall of all ED-530XT duodenoscopes. This action includes replacement of the ED-530XT forceps elevator mechanism including the O-ring seal, replacement of the distal end cap, and new Operation...

Posted today in Medical

What's Ahead for Health Reform in 2018?

The Republican Party's quest to undo the Affordable Care Act -- either by replacing it, repealing it or letting it fail -- is creating enormous uncertainty for millions of Americans who buy their own health insurance. Senate Republicans huddled again Wednesday night to discuss a path forward on health care after several doomed attempts to move bills...

Posted today in Medical

An 'Active' Workstation Won't Lower Your Job Performance

Companies needn't worry that job performance will suffer when employees use "active" workstations that come with potentially distracting treadmills, bikes or ellipticals. New research shows that most of the thinking skills needed to get through a typical workday are "not impaired while working on the active workstation," said study author Brandon Alderman. The...

Posted 3 days ago in New Drug Approvals

FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back....

Posted 2 days ago in New Drug Approvals

FDA Approves Vosevi (sofosbuvir/velpatasvir/voxilaprevir) for Re-Treatment of Adults with Chronic Hepatitis C Virus

(BUSINESS WIRE)--Jul. 18, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vosevi (sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg) tablets, a single-tablet regimen for the re-treatment of chronic hepatitis C virus (HCV) infection in adults with genotype 1, 2, 3, 4, 5...

Posted today in Medical

Health Tip: Eat Less Sugar

-- Too much sugar makes you gain weight and can harm your health. And you have to be especially careful about how much sugar you eat if you have diabetes. The American Heart Association advises: Not adding table sugar, syrup or honey to cereal, coffee, tea or pancakes. If you must add sugar, add half the usual amount. Drinking more water and avoiding...

Posted today in Medical

Health Highlights: July 21, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Linkin Park Singer Chester Bennington Dead at 41 Chester Bennington, the lead singer of the rock band Linkin Park, has died at age 41 in what is being investigated as a possible suicide. The death was confirmed by Brian Elias, the chief of operations...

Posted today in Medical

Health Tip: If Heartburn Doesn't Go Away

-- If eating the right foods and taking medication doesn't ease your heartburn, there may be a bigger issue. The American College of Gastroenterology says you should be concerned about heartburn symptoms if you're: Having a difficult time swallowing or feeling that you have food stuck in your chest. Vomiting blood, or seeing blood in your bowel movements,...

Posted today in Medical

Estrogen May Influence Women's Depression Risk

Women exposed to estrogen for longer periods of time during the reproductive years may have a lower risk of depression, a new study finds. Previous research has suggested that reproductive hormones play a role in depression risk among women, yet hormone fluctuations are something all women experience. So, the study authors tried to figure out how hormones...

Posted today in Medical

Blame Diabetes: Rates of 2 Nerve Conditions on the Rise

Two particular types of nerve damage -- neuropathy -- have been increasing as more and more people develop diabetes in the United States, an expert says. Autonomic and small fiber neuropathy were once rare conditions. Both occur when small blood vessels supplying the nerves are damaged by diabetes because they don't get enough oxygen and nutrients,...

Recently added consumer and prescribing information: Vosevi, Nerlynx, Tremfya, Bevyxxa, Rituxan Hycela, Baxdela, Imfinzi, Radicava, Kevzara, Tymlos

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]